swog
No description yet: the sentence for this tag has not been written. 6 records carry it: 6 people.
Related tags
6 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Heinz-Josef Lenz Professor of Medicine and Co-Director, Colorectal Center, USC Norris Comprehensive Cancer Center · USC Norris Comprehensive Cancer Center Colorectal oncologist who led CheckMate 142 and co-led CheckMate 8HW, bringing nivolumab plus ipilimumab to MSI-high disease. | Colorectal cancer | none | colorectal, immunotherapy | ||
Kevin Kalinsky Director, Glenn Family Breast Center, Winship Cancer Institute of Emory University · Winship Cancer Institute of Emory University Led RxPONDER, which showed postmenopausal women with 1-3 positive nodes and low recurrence scores do not need chemotherapy. | HR-positive / HER2-negative breast cancer | none | breast, de-escalation | ||
Maha Hussain Genevieve E. Teuton Professor of Medicine and Deputy Director, Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Robert H. Lurie Comprehensive Cancer Center of Northwestern University Led PROSPER and the PROfound survival analysis, and settled the intermittent hormone therapy question with SWOG 9346. | Prostate cancer | none | prostate, parp | ||
Sagar Lonial Chair of Hematology and Medical Oncology and Chief Medical Officer, Winship Cancer Institute of Emory University · Winship Cancer Institute of Emory University Led SIRIUS and the DREAMM programme, bringing daratumumab monotherapy and the BCMA ADC belantamab to myeloma. | Multiple myeloma | none | myeloma, adc | ||
Sapna P. Patel Professor of Medicine and Director of Melanoma Medical Oncology, University of Colorado Cancer Center · University of Colorado Cancer Center Led SWOG S1801, the trial that showed giving pembrolizumab before surgery, not just after, improves outcomes in melanoma. | Melanoma, Uveal melanoma | none | melanoma, neoadjuvant | ||
Sumanta K. Pal Professor and Co-Director, Kidney Cancer Program, City of Hope · City of Hope Led SWOG 1500, the first randomised trial to set a standard for papillary kidney cancer, and studies of the microbiome in RCC immunotherapy. | Renal cell carcinoma | none | rcc, microbiome |